Jerusalem, Israel

Michal Horowitz

USPTO Granted Patents = 3 

Average Co-Inventor Count = 7.0

ph-index = 3

Forward Citations = 27(Granted Patents)


Company Filing History:


Years Active: 2005-2007

Loading Chart...
3 patents (USPTO):Explore Patents

Title: Michal Horowitz: Innovator in Cannabinoid Research

Introduction

Michal Horowitz is a prominent inventor based in Jerusalem, Israel. He has made significant contributions to the field of cannabinoid research, particularly in developing novel pharmaceutical compositions. With a total of three patents to his name, Horowitz's work focuses on innovative treatments for various medical conditions.

Latest Patents

Horowitz's latest patents include groundbreaking inventions related to agonists specific for the peripheral cannabinoid receptor. These inventions provide novel pharmaceutical compositions that comprise 4-phenyl pinene derivatives, which specifically target peripheral cannabinoid receptors. Notably, these compounds bind efficiently to CB2 receptors while showing no binding affinity to CB1 receptors. This specificity is crucial as the compounds demonstrate no activity in behavioral tests in mice, which are typically associated with tetrahydrocannabinol (THC)-type activity mediated by CB1. Instead, they exhibit beneficial effects such as reducing blood pressure, blocking intestinal motility, and providing anti-inflammatory and peripheral analgesic activity. The inventions also encompass methods for treating, preventing, or managing hypertension, inflammation, pain, gastrointestinal diseases, autoimmune diseases, and tumors.

Career Highlights

Horowitz is affiliated with Yissum Research Development Company of the Hebrew University of Jerusalem Ltd. His work at Yissum has allowed him to explore and develop innovative solutions in the pharmaceutical field. His research has garnered attention for its

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…